vs

Side-by-side financial comparison of General Enterprise Ventures, Inc. (CITR) and 60 DEGREES PHARMACEUTICALS, INC. (SXTP). Click either name above to swap in a different company.

60 DEGREES PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($303.4K vs $288.2K, roughly 1.1× General Enterprise Ventures, Inc.). 60 DEGREES PHARMACEUTICALS, INC. runs the higher net margin — -474.2% vs -2751.2%, a 2277.0% gap on every dollar of revenue. On growth, General Enterprise Ventures, Inc. posted the faster year-over-year revenue change (169.3% vs 25.6%). General Enterprise Ventures, Inc. produced more free cash flow last quarter ($-1.5M vs $-1.8M). Over the past eight quarters, General Enterprise Ventures, Inc.'s revenue compounded faster (218.8% CAGR vs 69.4%).

The Hewlett Packard Enterprise Company (HPE) is an American multinational information technology company based in Spring, Texas. It is a business-focused organization which works in servers, storage, networking, containerization software and consulting and support. HPE was ranked No. 107 in the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

CITR vs SXTP — Head-to-Head

Bigger by revenue
SXTP
SXTP
1.1× larger
SXTP
$303.4K
$288.2K
CITR
Growing faster (revenue YoY)
CITR
CITR
+143.7% gap
CITR
169.3%
25.6%
SXTP
Higher net margin
SXTP
SXTP
2277.0% more per $
SXTP
-474.2%
-2751.2%
CITR
More free cash flow
CITR
CITR
$257.5K more FCF
CITR
$-1.5M
$-1.8M
SXTP
Faster 2-yr revenue CAGR
CITR
CITR
Annualised
CITR
218.8%
69.4%
SXTP

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CITR
CITR
SXTP
SXTP
Revenue
$288.2K
$303.4K
Net Profit
$-7.9M
$-1.4M
Gross Margin
-99.7%
60.2%
Operating Margin
-1470.3%
-632.0%
Net Margin
-2751.2%
-474.2%
Revenue YoY
169.3%
25.6%
Net Profit YoY
-1110.1%
29.7%
EPS (diluted)
$-0.59
$-8.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CITR
CITR
SXTP
SXTP
Q4 25
$303.4K
Q3 25
$288.2K
$437.6K
Q2 25
$687.6K
$100.9K
Q1 25
$969.4K
$163.6K
Q4 24
$241.6K
Q3 24
$135.3K
Q2 24
$198.7K
$125.0K
Q1 24
$433.0K
$105.7K
Net Profit
CITR
CITR
SXTP
SXTP
Q4 25
$-1.4M
Q3 25
$-7.9M
$-2.3M
Q2 25
$-11.9M
$-1.7M
Q1 25
$-10.9M
$-1.9M
Q4 24
$-2.0M
Q3 24
$-2.2M
Q2 24
$-907.4K
$-4.2M
Q1 24
$-3.5M
$430.5K
Gross Margin
CITR
CITR
SXTP
SXTP
Q4 25
60.2%
Q3 25
-99.7%
-22.9%
Q2 25
46.0%
50.4%
Q1 25
42.5%
55.2%
Q4 24
51.1%
Q3 24
17.4%
Q2 24
48.6%
28.3%
Q1 24
79.2%
38.1%
Operating Margin
CITR
CITR
SXTP
SXTP
Q4 25
-632.0%
Q3 25
-1470.3%
-531.4%
Q2 25
-438.8%
-1590.0%
Q1 25
-356.8%
-1168.4%
Q4 24
-854.7%
Q3 24
-1566.0%
Q2 24
-456.7%
-3351.8%
Q1 24
-608.9%
-1270.4%
Net Margin
CITR
CITR
SXTP
SXTP
Q4 25
-474.2%
Q3 25
-2751.2%
-529.3%
Q2 25
-1731.1%
-1717.7%
Q1 25
-1124.8%
-1147.4%
Q4 24
-846.3%
Q3 24
-1596.4%
Q2 24
-456.7%
-3339.0%
Q1 24
-812.8%
407.4%
EPS (diluted)
CITR
CITR
SXTP
SXTP
Q4 25
$-8.26
Q3 25
$-0.59
$-0.66
Q2 25
$-0.19
$-1.25
Q1 25
$-0.23
$-1.56
Q4 24
$-51.96
Q3 24
$-2.92
Q2 24
$-0.02
$-21.12
Q1 24
$-0.04
$1.83

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CITR
CITR
SXTP
SXTP
Cash + ST InvestmentsLiquidity on hand
$2.8M
Total DebtLower is stronger
$150.0K
Stockholders' EquityBook value
$8.5M
$3.5M
Total Assets
$12.3M
$5.4M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CITR
CITR
SXTP
SXTP
Q4 25
$2.8M
Q3 25
$4.1M
Q2 25
$2.0M
Q1 25
$3.5M
Q4 24
$3.4M
Q3 24
$5.0M
Q2 24
$1.6M
Q1 24
Total Debt
CITR
CITR
SXTP
SXTP
Q4 25
$150.0K
Q3 25
$150.0K
Q2 25
$150.0K
Q1 25
$150.0K
Q4 24
$150.0K
Q3 24
$150.0K
Q2 24
$150.0K
Q1 24
$150.0K
Stockholders' Equity
CITR
CITR
SXTP
SXTP
Q4 25
$3.5M
Q3 25
$8.5M
$4.4M
Q2 25
$2.2M
$2.4M
Q1 25
$4.1M
$4.1M
Q4 24
$4.0M
Q3 24
$6.0M
Q2 24
$3.2M
$3.0M
Q1 24
$3.8M
$7.2M
Total Assets
CITR
CITR
SXTP
SXTP
Q4 25
$5.4M
Q3 25
$12.3M
$6.7M
Q2 25
$8.7M
$4.2M
Q1 25
$9.1M
$6.0M
Q4 24
$5.8M
Q3 24
$7.4M
Q2 24
$5.4M
$4.3M
Q1 24
$5.3M
$8.4M
Debt / Equity
CITR
CITR
SXTP
SXTP
Q4 25
0.04×
Q3 25
0.03×
Q2 25
0.06×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.02×
Q2 24
0.05×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CITR
CITR
SXTP
SXTP
Operating Cash FlowLast quarter
$-1.5M
$-1.7M
Free Cash FlowOCF − Capex
$-1.5M
$-1.8M
FCF MarginFCF / Revenue
-525.6%
-584.2%
Capex IntensityCapex / Revenue
18.7%
26.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CITR
CITR
SXTP
SXTP
Q4 25
$-1.7M
Q3 25
$-1.5M
$-2.1M
Q2 25
$-1.2M
$-1.5M
Q1 25
$-713.9K
$-1.6M
Q4 24
$-1.6M
Q3 24
$-1.7M
Q2 24
$-424.9K
$-1.2M
Q1 24
$-343.7K
$-1.1M
Free Cash Flow
CITR
CITR
SXTP
SXTP
Q4 25
$-1.8M
Q3 25
$-1.5M
$-2.1M
Q2 25
$-1.4M
$-1.5M
Q1 25
$-740.9K
$-1.6M
Q4 24
Q3 24
$-1.7M
Q2 24
Q1 24
FCF Margin
CITR
CITR
SXTP
SXTP
Q4 25
-584.2%
Q3 25
-525.6%
-484.2%
Q2 25
-196.7%
-1483.6%
Q1 25
-76.4%
-978.3%
Q4 24
Q3 24
-1252.8%
Q2 24
Q1 24
Capex Intensity
CITR
CITR
SXTP
SXTP
Q4 25
26.3%
Q3 25
18.7%
2.3%
Q2 25
20.5%
46.9%
Q1 25
2.8%
1.6%
Q4 24
Q3 24
10.2%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
CITR
CITR
SXTP
SXTP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-2.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons